MRI T1 mapping for the assessment of the prostate: a new diagnostic tool
08:00Johannes Uhlig, Goettingen / DE
2
Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
08:00Francesco Giganti, London / UK
3
Time-series radiomics outperforms conventional radiomics approaches for the prediction of prostate cancer histopathological progression on active surveillance
08:00Nikita Sushentsev, Cambridge / UK
4
Strategy of target biopsy and number of target cores for a PI-RADS 3-5 index lesion to reduce Gleason score underestimation: a propensity score-matching analysis
08:00Byung Kwan Park, Seoul / KR
5
Vector prostate biopsy: a novel electro-magnetic biopsy technique for mpMRI/US fusion transperineal prostate biopsies under local anaesthesia
08:00Peter Fletcher, Cambridge / UK
6
Analysis of dose distribution at organs at risk in patients with early stage prostate cancer treated with the robotic stereotactic body radiation therapy (SBRT) and pencil-beam scanning proton therapy
08:00Nikita Kataev, Saint-Petersburg / RU
7
Effects of dynamic contrast enhancement on transition-zone prostate cancer in PI-RADS version 2.1
08:00Jiahui Zhang, Beijing / CN
8
Utility of 2D shear-wave elastography for the detection of prostate cancer: a preliminary study
08:00Chan Kyo Kim, Seoul / KR
9
Promoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship